Original Article
Efficacy and Tolerability of Rituximab in Patients With Rhupus
Eficacia y tolerabilidad de rituximab en el tratamiento de pacientes con rhupus
Lilia Andrade-Ortega
, Fedra Irazoque-Palazuelos, Sandra Muñóz-López, Victor Manuel Rosales-Don Pablo
Corresponding author
Servicio de Reumatología, Centro Médico Nacional 20 de Noviembre, ISSSTE, México, D.F., Mexico
Read
9222
Timeswas read the article
2549
Total PDF
6673
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 3 | 22 | 25 |
| 2025 5 | 391 | 45 | 436 |
| 2025 4 | 186 | 32 | 218 |
| 2025 3 | 133 | 26 | 159 |
| 2025 2 | 120 | 35 | 155 |
| 2025 1 | 88 | 36 | 124 |
| 2024 12 | 84 | 32 | 116 |
| 2024 11 | 85 | 59 | 144 |
| 2024 10 | 68 | 34 | 102 |
| 2024 9 | 87 | 30 | 117 |
| 2024 8 | 86 | 41 | 127 |
| 2024 7 | 71 | 25 | 96 |
| 2024 6 | 52 | 24 | 76 |
| 2024 5 | 55 | 33 | 88 |
| 2024 4 | 53 | 24 | 77 |
| 2024 3 | 73 | 19 | 92 |
| 2024 2 | 31 | 17 | 48 |
| 2024 1 | 42 | 30 | 72 |
| 2023 12 | 31 | 23 | 54 |
| 2023 11 | 29 | 24 | 53 |
| 2023 10 | 52 | 26 | 78 |
| 2023 9 | 83 | 44 | 127 |
| 2023 8 | 49 | 15 | 64 |
| 2023 7 | 41 | 27 | 68 |
| 2023 6 | 37 | 28 | 65 |
| 2023 5 | 64 | 22 | 86 |
| 2023 4 | 23 | 7 | 30 |
| 2023 3 | 54 | 23 | 77 |
| 2023 2 | 46 | 35 | 81 |
| 2023 1 | 34 | 16 | 50 |
| 2022 12 | 55 | 29 | 84 |
| 2022 11 | 34 | 31 | 65 |
| 2022 10 | 38 | 33 | 71 |
| 2022 9 | 72 | 33 | 105 |
| 2022 8 | 66 | 42 | 108 |
| 2022 7 | 68 | 40 | 108 |
| 2022 6 | 37 | 26 | 63 |
| 2022 5 | 55 | 46 | 101 |
| 2022 4 | 52 | 48 | 100 |
| 2022 3 | 43 | 53 | 96 |
| 2022 2 | 31 | 31 | 62 |
| 2022 1 | 38 | 33 | 71 |
| 2021 12 | 24 | 35 | 59 |
| 2021 11 | 44 | 40 | 84 |
| 2021 10 | 49 | 40 | 89 |
| 2021 9 | 34 | 35 | 69 |
| 2021 8 | 46 | 40 | 86 |
| 2021 7 | 28 | 26 | 54 |
| 2021 6 | 45 | 35 | 80 |
| 2021 5 | 51 | 44 | 95 |
| 2021 4 | 167 | 78 | 245 |
| 2021 3 | 148 | 28 | 176 |
| 2021 2 | 152 | 13 | 165 |
| 2021 1 | 50 | 17 | 67 |
| 2020 12 | 47 | 15 | 62 |
| 2020 11 | 42 | 12 | 54 |
| 2020 10 | 29 | 15 | 44 |
| 2020 9 | 33 | 22 | 55 |
| 2020 8 | 24 | 9 | 33 |
| 2020 7 | 18 | 10 | 28 |
| 2020 6 | 33 | 30 | 63 |
| 2020 5 | 30 | 16 | 46 |
| 2020 4 | 28 | 12 | 40 |
| 2020 3 | 10 | 8 | 18 |
| 2020 2 | 1 | 0 | 1 |
| 2019 4 | 2 | 1 | 3 |
| 2019 1 | 1 | 0 | 1 |
| 2018 6 | 0 | 2 | 2 |
| 2018 5 | 4 | 3 | 7 |
| 2018 4 | 42 | 14 | 56 |
| 2018 3 | 48 | 18 | 66 |
| 2018 2 | 44 | 3 | 47 |
| 2018 1 | 44 | 7 | 51 |
| 2017 12 | 51 | 7 | 58 |
| 2017 11 | 37 | 9 | 46 |
| 2017 10 | 56 | 14 | 70 |
| 2017 9 | 41 | 4 | 45 |
| 2017 8 | 41 | 13 | 54 |
| 2017 7 | 46 | 20 | 66 |
| 2017 6 | 52 | 10 | 62 |
| 2017 5 | 47 | 16 | 63 |
| 2017 4 | 41 | 5 | 46 |
| 2017 3 | 52 | 39 | 91 |
| 2017 2 | 62 | 11 | 73 |
| 2017 1 | 46 | 5 | 51 |
| 2016 12 | 95 | 22 | 117 |
| 2016 11 | 89 | 9 | 98 |
| 2016 10 | 130 | 17 | 147 |
| 2016 9 | 172 | 20 | 192 |
| 2016 8 | 88 | 4 | 92 |
| 2016 7 | 53 | 7 | 60 |
| 2016 6 | 0 | 18 | 18 |
| 2016 5 | 2 | 15 | 17 |
| 2016 4 | 1 | 0 | 1 |
| 2015 12 | 3 | 0 | 3 |
| 2015 11 | 1 | 0 | 1 |
| 2015 10 | 1 | 15 | 16 |
| 2015 9 | 3 | 0 | 3 |
| 2015 7 | 18 | 6 | 24 |
| 2015 6 | 55 | 5 | 60 |
| 2015 5 | 66 | 15 | 81 |
| 2015 4 | 53 | 11 | 64 |
| 2015 3 | 60 | 8 | 68 |
| 2015 2 | 91 | 8 | 99 |
| 2015 1 | 47 | 10 | 57 |
| 2014 12 | 62 | 13 | 75 |
| 2014 11 | 54 | 8 | 62 |
| 2014 10 | 47 | 11 | 58 |
| 2014 9 | 31 | 9 | 40 |
| 2014 8 | 30 | 12 | 42 |
| 2014 7 | 38 | 15 | 53 |
| 2014 6 | 84 | 17 | 101 |
| 2014 5 | 49 | 16 | 65 |
| 2014 4 | 59 | 12 | 71 |
| 2014 3 | 64 | 21 | 85 |
| 2014 2 | 48 | 15 | 63 |
| 2014 1 | 50 | 17 | 67 |
| 2013 12 | 39 | 9 | 48 |
| 2013 11 | 37 | 10 | 47 |
| 2013 10 | 55 | 16 | 71 |
| 2013 9 | 46 | 31 | 77 |
| 2013 8 | 74 | 30 | 104 |
| 2013 7 | 48 | 17 | 65 |
Show all
